Wiberg Cleveland posted an update 1 week, 3 days ago
Seen from results from Lab evaluation, the U.S. FDA has determined that Zantac® and other ranitidine medicines have a nitrosamine issue named N–nitrosodimethylamine (NDMA) at lower concentrations. NDMA is thought of as a probable human carcinogen – a substance which could cause cancer in humans. NDMA is a classified environmental contaminant and noticed in water and food sources, including meat, dairy items, and produce.
What is NDMA?
N–nitrosodimethylamine (NDMA) is known as a probable human carcinogen which means that it’s more likely than not to cause cancer in humans. NDMA has been studied in animal populations and found to increase the occurrence of cancer in the animals. The studies have increased the opportunity of an connection between NDMA and liver toxicity that might continue to the development of liver cancer and various connected conditions created by an NDMA–induced treatment of the liver.
The degree and length of human NDMA exposure which can lead to the development of cancer is not exactly known. Similarly, the amount and duration of the NDMA contamination of Zantac® and various ranitidine medications are not exactly understood.
Diseases Associated with Exposure to NDMA
NDMA has been studied in animal groups and determined to increase the occurrence of cancer in the animals. In
zantac of these studies, the US EPA classifies NDMA as a likely human carcinogen. The research has raised the probability of a connection between NDMA and liver toxicity that may lead to the development of liver cancer and various associated conditions brought about by an NDMA injury to the liver. Some have suggested that NDMA could also be linked to other cancers such as:
Small Intestine Cancer, Colorectal Cancer, Prostate Cancer, Non–Hodgkin’s Lymphoma.
Have Other Ranitidine Products Been Recalled?
Yes. The U.S. Food and Drug Administration has alerted health care professionals and consumers to three existing voluntary recalls of ranitidine.
Perrigo Company plc has voluntarily recalled over–the–counter (OTC) ranitidine tablets due to the possibility of N–Nitrosodimethylamine (NDMA) in the medicine.
Novitium Pharma LLC has voluntarily recalled all unexpired amounts and lots of ranitidine hydrochloride medication due to the possibility of NDMA in the medicine.
Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup due to the presence of NDMA found in the drug.
Should I Cease Taking Zantac® or Other Ranitidine Medications?
As of October 28, 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medications as follows:
“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. Consumers taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. FDA’s testing of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”
Meneo Law Group is a leading consumer law firm for the recovery of damages due to NDMA injury. Feel free to contact us at any time to discuss your injury and potential for recovery.